Abstract
The study suggests an association between berberine's cardioprotective effects and Notch signaling pathway modulation in the context of myocardial ischemia-reperfusion injury. While berberine was found to bind Notch1 and affect gene and protein expression related to apoptosis, further research is necessary to determine whether these effects directly contribute to reduced apoptosis and enhanced cell survival.
Introduction
In cardiovascular medicine, ischemia-reperfusion (I/R) injury presents a significant clinical challenge. While restoring blood flow is the primary goal following a heart attack, the sudden return of oxygenated blood can trigger a secondary wave of tissue damage, inflammation, and cell death. Berberine, a natural plant alkaloid, has long been recognized for its anti-inflammatory properties, but its specific mechanism of cardioprotection has remained unclear. This study investigates whether berberine’s protective effects are linked to the Notch signaling pathway, a critical regulator of cell survival.
Methods
The researchers utilized a multi-scale approach to evaluate berberine's efficacy:
- In Vivo Model: Sprague-Dawley rats underwent surgery to simulate I/R injury (30 minutes of occlusion followed by 72 hours of reperfusion). One group received oral berberine for two weeks prior to the procedure.
- In Vitro Model: H9c2 rat myocardial cells were subjected to hypoxia and reoxygenation to mimic I/R injury at the cellular level.
- Molecular Interaction: Computational molecular docking and Microscale Thermophoresis (MST) were employed to quantify the binding affinity between berberine and the Notch1 receptor.
- Biological Assays: TTC staining was used to measure infarct size, while TUNEL staining and qPCR/Immunofluorescence tracked markers of apoptosis and gene expression (Notch1, Hes1, Bcl-2, and Bax).
Key Results
Infarct Reduction and Structural Preservation
Berberine treatment led to a statistically significant reduction in myocardial infarct size compared to the untreated I/R model group. Quantitative analysis of TTC staining confirmed this protective effect, showing a marked decrease in the percentage of dead tissue.
Histological examination further supported these findings. While the model group showed significant tissue disruption and fiber misalignment, the berberine-treated hearts maintained better muscle fiber organization and structural integrity.
Molecular Mechanism: The Notch1 Connection
The study identified a direct physical interaction between berberine and the Notch1 receptor. Molecular docking predicted a strong binding energy of –10.43 kcal/mol, and MST calculations confirmed a high-affinity bond ($K_d = 2.35 \times 10^{-6}$ M). This binding was associated with the upregulation of Notch1 and its downstream target Hes1. Furthermore, berberine effectively reversed the pro-apoptotic signaling typical of I/R injury by increasing the expression of the survival protein Bcl-2 and decreasing the pro-apoptotic protein Bax.
Discussion and Limitations
The findings suggest that berberine exerts its cardioprotective effects by targeting the Notch1 signaling pathway, thereby suppressing apoptosis and maintaining myocardial integrity. However, several limitations remain. While a strong correlation exists between berberine binding and improved outcomes, further research using Notch inhibitors is necessary to prove direct causality. Additionally, as the study utilized a two-week pre-treatment in rats, future work must investigate whether berberine can serve as an acute intervention in human clinical settings where treatment is typically administered after the onset of injury.
Summary updated